Literature DB >> 12971990

Expression of BEN, a member of TFII-I family of transcription factors, during mouse pre- and postimplantation development.

Dashzeveg Bayarsaihan1, Natalia Bitchevaia, Badam Enkhmandakh, Maria Isabel Tussie-Luna, James F Leckman, Ananda Roy, Frank Ruddle.   

Abstract

BEN is a member of the TFII-I family of transcription factors, characterized by the presence of multiple helix-loop-helix repeat domains. Our immunohistochemical analysis demonstrated broad and extensive expression of BEN during mouse pre- and postimplantation development, with highest levels occurring during early to midgestation. Maternally expressed BEN is present in both the cytoplasm and nuclei of the zygote; however, it retains a predominantly nuclear localization between the two-cell stage of development and early blastocyst stages. This nuclear expression is observed in most tissues throughout development. Although, it is interesting to note that at E4.5-6.5, during early gastrulation stage, BEN is localized in the cytoplasm. At later stages, BEN retains an extensive expression pattern in a variety of developing systems implicating its involvement in tissue development and organogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12971990     DOI: 10.1016/s1567-133x(03)00118-2

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  10 in total

1.  Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits.

Authors:  Anna Antonell; Mireia Vilardell; Luis A Pérez Jurado
Journal:  Hum Genet       Date:  2010-04-17       Impact factor: 4.132

2.  Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors.

Authors:  Manching Ku; Sergei Y Sokol; Jack Wu; Maria Isabel Tussie-Luna; Ananda L Roy; Akiko Hata
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

3.  Visual phenotype in Williams-Beuren syndrome challenges magnocellular theories explaining human neurodevelopmental visual cortical disorders.

Authors:  Miguel Castelo-Branco; Mafalda Mendes; Ana Raquel Sebastião; Aldina Reis; Mário Soares; Jorge Saraiva; Rui Bernardes; Raquel Flores; Luis Pérez-Jurado; Eduardo Silva
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

4.  Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.

Authors:  Badam Enkhmandakh; Aleksandr V Makeyev; Lkhamsuren Erdenechimeg; Frank H Ruddle; Nyam-Osor Chimge; Maria Isabel Tussie-Luna; Ananda L Roy; Dashzeveg Bayarsaihan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

5.  Is it Williams syndrome? GTF2IRD1 implicated in visual-spatial construction and GTF2I in sociability revealed by high resolution arrays.

Authors:  L Dai; U Bellugi; X-N Chen; A M Pulst-Korenberg; A Järvinen-Pasley; T Tirosh-Wagner; P S Eis; J Graham; D Mills; Y Searcy; J R Korenberg
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

6.  Alternative splicing and promoter use in TFII-I genes.

Authors:  Aleksandr V Makeyev; Dashzeveg Bayarsaihan
Journal:  Gene       Date:  2008-12-09       Impact factor: 3.688

7.  Determination and functional analysis of the consensus binding site for TFII-I family member BEN, implicated in Williams-Beuren syndrome.

Authors:  Maria B Lazebnik; Maria Isabel Tussie-Luna; Ananda L Roy
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

8.  Diversity and complexity in chromatin recognition by TFII-I transcription factors in pluripotent embryonic stem cells and embryonic tissues.

Authors:  Aleksandr V Makeyev; Badam Enkhmandakh; Seung-Hyun Hong; Pujan Joshi; Dong-Guk Shin; Dashzeveg Bayarsaihan
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

9.  Global analysis of gene expression in the developing brain of Gtf2ird1 knockout mice.

Authors:  Jennifer O'Leary; Lucy R Osborne
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

10.  Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.

Authors:  Kate Lawrenson; Qiyuan Li; Siddhartha Kar; Ji-Heui Seo; Jonathan Tyrer; Tassja J Spindler; Janet Lee; Yibu Chen; Alison Karst; Ronny Drapkin; Katja K H Aben; Hoda Anton-Culver; Natalia Antonenkova; Helen Baker; Elisa V Bandera; Yukie Bean; Matthias W Beckmann; Andrew Berchuck; Maria Bisogna; Line Bjorge; Natalia Bogdanova; Louise A Brinton; Angela Brooks-Wilson; Fiona Bruinsma; Ralf Butzow; Ian G Campbell; Karen Carty; Jenny Chang-Claude; Georgia Chenevix-Trench; Anne Chen; Zhihua Chen; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Cezary Cybulski; Agnieszka Dansonka-Mieszkowska; Joe Dennis; Ed Dicks; Jennifer A Doherty; Thilo Dörk; Andreas du Bois; Matthias Dürst; Diana Eccles; Douglas T Easton; Robert P Edwards; Ursula Eilber; Arif B Ekici; Peter A Fasching; Brooke L Fridley; Yu-Tang Gao; Aleksandra Gentry-Maharaj; Graham G Giles; Rosalind Glasspool; Ellen L Goode; Marc T Goodman; Jacek Grownwald; Patricia Harrington; Philipp Harter; Hanis Nazihah Hasmad; Alexander Hein; Florian Heitz; Michelle A T Hildebrandt; Peter Hillemanns; Estrid Hogdall; Claus Hogdall; Satoyo Hosono; Edwin S Iversen; Anna Jakubowska; Paul James; Allan Jensen; Bu-Tian Ji; Beth Y Karlan; Susanne Kruger Kjaer; Linda E Kelemen; Melissa Kellar; Joseph L Kelley; Lambertus A Kiemeney; Camilla Krakstad; Jolanta Kupryjanczyk; Diether Lambrechts; Sandrina Lambrechts; Nhu D Le; Alice W Lee; Shashi Lele; Arto Leminen; Jenny Lester; Douglas A Levine; Dong Liang; Jolanta Lissowska; Karen Lu; Jan Lubinski; Lene Lundvall; Leon F A G Massuger; Keitaro Matsuo; Valerie McGuire; John R McLaughlin; Heli Nevanlinna; Ian McNeish; Usha Menon; Francesmary Modugno; Kirsten B Moysich; Steven A Narod; Lotte Nedergaard; Roberta B Ness; Mat Adenan Noor Azmi; Kunle Odunsi; Sara H Olson; Irene Orlow; Sandra Orsulic; Rachel Palmieri Weber; Celeste L Pearce; Tanja Pejovic; Liisa M Pelttari; Jennifer Permuth-Wey; Catherine M Phelan; Malcolm C Pike; Elizabeth M Poole; Susan J Ramus; Harvey A Risch; Barry Rosen; Mary Anne Rossing; Joseph H Rothstein; Anja Rudolph; Ingo B Runnebaum; Iwona K Rzepecka; Helga B Salvesen; Joellen M Schildkraut; Ira Schwaab; Thomas A Sellers; Xiao-Ou Shu; Yurii B Shvetsov; Nadeem Siddiqui; Weiva Sieh; Honglin Song; Melissa C Southey; Lara Sucheston; Ingvild L Tangen; Soo-Hwang Teo; Kathryn L Terry; Pamela J Thompson; Agnieszka Timorek; Ya-Yu Tsai; Shelley S Tworoger; Anne M van Altena; Els Van Nieuwenhuysen; Ignace Vergote; Robert A Vierkant; Shan Wang-Gohrke; Christine Walsh; Nicolas Wentzensen; Alice S Whittemore; Kristine G Wicklund; Lynne R Wilkens; Yin-Ling Woo; Xifeng Wu; Anna H Wu; Hannah Yang; Wei Zheng; Argyrios Ziogas; Alvaro Monteiro; Paul D Pharoah; Simon A Gayther; Matthew L Freedman
Journal:  Nat Commun       Date:  2015-09-22       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.